Nanotechnology Engineering alumna leverages skills to advance women’s health
Cervical cancer is diagnosed in over 1,000 Canadian women each year, and approximately 410 women die from the disease annually. Women need to undergo regular cervical cancer screening, as early detection can significantly increase the chances of successful treatment.
However, in Ontario, women are only eligible for the Pap Test (or Pap smear) every three years. CT Murphy a Nanotechnology Engineering (NE) graduate (BASc ’23) aims to create a new testing method that allows women to screen for the human papillomavirus (HPV) that usually causes cervical cancer.